Yasushi Okoshi

• Katsushige Inada, Yasushi Okoshi, Yukiko Cho-Isoda, Shingo Ishiguro, Hisashi Suzuki, Akinori Oki, Yoshio Tamaki, Toru Shimazui, Hitoaki Saito, Mitsuo Hori, et al. Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue. Scientific Reports. 2018. 8. 1. 5918
• Kajikawa, Natsuki, Seki, Yoshimoto, Fujio, Takayuki, Okoshi, Yasushi, Hori, Mitsuo, Saito, Hitoaki, Iijima, Tatsuo, Kojima, Hiroshi. Central Nervous System Lymphoma Harboring the JAK2 V617F Mutation that Developed after a 20-year History of Polycythemia Vera. Internal medicine (Tokyo, Japan). 2018. 57. 22. 3293-3297
• Keiichiro Hattori, Mamiko Sakata-Yanagimoto, Yasushi Okoshi, Takayasu Kato, Naoki Kurita, Yasuhisa Yokoyama, Naoshi Obara, Shingo Takano, Eiichi Ishikawa, Tetsuya Yamamoto, et al. A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine. Journal of clinical and experimental hematopathology : JCEH. 2017. 57. 2. 41-46
• Hattori, Keiichiro, Sakata-Yanagimoto, Mamiko, Okoshi, Yasushi, Kato, Takayasu, Kurita, Naoki, Yokoyama, Yasuhisa, Obara, Naoshi, Takano, Shingo, Ishikawa, Eiichi, Yamamoto, Tetsuya, et al. A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine. Journal of Clinical and Experimental Hematopathology. 2017. 57. 2. 41-46
• Keiichiro Hattori, Mamiko Sakata-Yanagimoto, Yasushi Okoshi, Yuki Goshima, Shintaro Yanagimoto, Rie Nakamoto-Matsubara, Taiki Sato, Masayuki Noguchi, Shingo Takano, Eichi Ishikawa, et al. MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma. British Journal of Haematology. 2017. 177. 3. 492-494

ｍore...

• 分子レベルからみたT/NK細胞分化
  血液・腫瘍科 2005
• Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3.
  2005
• ペアレセプターMAIR-I・MAIR-IIによる骨髄球系細胞の活性化制御機構
  Molecular Medicine 臨時増刊号 免疫2005 2004
• MAIRファミリー分子と正と負の自然免疫制御
  Annual Review 免疫 2004 2003
• KIR (Killer cell Immunoglobulin-like receptors)
  分子細胞治療、第2号 2003

ｍore...

• 患者教育を含めたチーム医療によるトラベクテジンの安全な投与管理方法.
  (第16回日本臨床腫瘍学会学術集会 2018)
• Reference gene selection for microRNA quantitation in lymph node tissue
  (第76回日本癌学会学術総会 2017)
• 産科施設で適正に管理された血液製剤の返却・転用の実現性についての調査研究-茨城県合同輸血療法委員会
  (第65回日本輸血・細胞治療学会総会 2017)
• 産科施設で適切に管理された血液製剤の返却・転用の実現性についての調査研究-茨城県合同輸血委員会.
  (第65回日本輸血・細胞治療学会総会 2017)
• The prognostic impact of c-kit D816 mutations in core binding factor acute myeloid leukemia
  (第78回日本血液学会学術集会 2016)

ｍore...

• 2001 - 2005 University of Tsukuba
• 1989 - 1995 University of Tsukuba

• 2011/10/01 - Faculty of Medicine, University of Tsukuba
• 2005/04/01 - 2011/09/30 Graduate School of Comprehensive Human Sciences, University of Tsukuba
• 1995/06/01 - 2001/03/30 University of Tsukuba University Hospital
• University of Tsukuba Faculty of Medicine Associate Professor

American Society of Hematology ,  Japan Society for Hematopoietic Cell Transplantation ,  The Japanese Cancer Association ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JANPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPAN SOCIETY OF TRANSFUSION MEDIEINE AND CELL THERPY